Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Walmsley

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|June 11, 2025
Monkeypox virus transcriptional profiles and host responses in skin lesion swabs among individuals with HIVJacklyn R Hurst, Darrell H S Tan, Abby Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2015
Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical TrialSharon Walmsley, Axel Baumgarten, Juan Berenguer, et al.
BMC Infectious Diseases|April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patientsTony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral TherapyJennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials|August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trialMarina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Journal of the International Association of Providers of AIDS Care|May 10, 2017
Exploring the Factors Considered by People Living with HIV and Their Partners during PreconceptionV Logan Kennedy, Micaela Collins, Mark H Yudin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2020
Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIVElisabeth McClymont, François Coutlée, Marette Lee, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIVAnna Cvetkovic, Elizabeth King, Lashanda Skerritt, et al.
AIDS Research and Therapy|March 22, 2024
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studiesSharon Walmsley, Don E Smith, Miguel Górgolas, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|June 11, 2025
Monkeypox virus transcriptional profiles and host responses in skin lesion swabs among individuals with HIVJacklyn R Hurst, Darrell H S Tan, Abby Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2015
Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical TrialSharon Walmsley, Axel Baumgarten, Juan Berenguer, et al.
BMC Infectious Diseases|April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patientsTony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral TherapyJennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials|August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trialMarina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Journal of the International Association of Providers of AIDS Care|May 10, 2017
Exploring the Factors Considered by People Living with HIV and Their Partners during PreconceptionV Logan Kennedy, Micaela Collins, Mark H Yudin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2020
Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIVElisabeth McClymont, François Coutlée, Marette Lee, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIVAnna Cvetkovic, Elizabeth King, Lashanda Skerritt, et al.
AIDS Research and Therapy|March 22, 2024
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studiesSharon Walmsley, Don E Smith, Miguel Górgolas, et al.
Pageof 20